key: cord-1050889-36ijzvox
authors: Jamal, Alainna J; Mozafarihashjin, Mohammad; Coomes, Eric; Powis, Jeff; Li, Angel X; Paterson, Aimee; Anceva-Sami, Sofia; Barati, Shiva; Crowl, Gloria; Faheem, Amna; Farooqi, Lubna; Khan, Saman; Prost, Karren; Poutanen, Susan; Taylor, Maureen; Yip, Lily; Zhong, Xi Zoe; McGeer, Allison J; Mubareka, Samira
title: Sensitivity of nasopharyngeal swabs and saliva for the detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
date: 2020-06-25
journal: Clin Infect Dis
DOI: 10.1093/cid/ciaa848
sha: edcc044f5a9ec5f7b749d382858e2a9f9f1f44ec
doc_id: 1050889
cord_uid: 36ijzvox

We enrolled 91 consecutive in-patients with COVID-19 at six hospitals in Toronto, Canada, and tested one nasopharyngeal swab/saliva sample pair from each patient using real-time reverse transcriptase polymerase chain reaction for SARS-CoV-2. Sensitivity was 89% for nasopharyngeal swabs and 72% for saliva (p=0.02); difference in sensitivity was greatest for sample pairs collected later in illness.

A c c e p t e d M a n u s c r i p t 4 

Rapid and accurate detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patient specimens is critical to controlling the coronavirus disease 2019 (COVID-19) pandemic. As yet, there are few data comparing sensitivity of different specimen types for SARS-CoV-2 detection.

In Canada, nasopharyngeal (NP) swabs are the preferred collection site for SARS-CoV-2 testing [1, 2] , and preliminary data suggest that they may be more sensitive than oropharyngeal swabs for SARS-CoV-2 detection [3, 4] . However, collection of both NP and oropharyngeal swabs is uncomfortable for patients and may pose risk to healthcare workers.

Moreover, recent global supply chain shortages have resulted in limited access to various swab types. Saliva, in contrast, can be easily self-collected by most adolescents and adults.

Other groups have demonstrated successful detection of SARS-CoV-2 in saliva specimens and use of saliva for serial sampling [5] [6] [7] . We aimed to compare sensitivity of NP swabs and saliva for SARS-CoV-2 detection in hospitalized patients.

The Toronto Invasive Bacterial Disease Network (TIBDN) performs population-based surveillance for select infectious diseases in metropolitan Toronto and the regional municipality of Peel (population base 4.2 million in 2016), Ontario, Canada. For COVID-19, clinical microbiology laboratories report specimens testing positive for SARS-CoV-2 to the central study office. Starting on March 16 th , 2020, study staff enrolled consecutive in-patients at 6 TIBDN hospitals. Patient demographic, exposure, and medical data were collected by interview and chart review. An NP swab and saliva specimen were collected on the day of A c c e p t e d M a n u s c r i p t 5 enrolment, and then 3 subsequent pairs of samples were obtained at 72-hour intervals if the patient remained hospitalized. NP swabs were collected as per standard procedures and placed into UTM ® viral transport medium (COPAN Diagnostics, California, US) [8] . For saliva specimens, patients were asked to spit one teaspoon (5 mL) of saliva into a sterile specimen container and then 2.5 mL of phosphate-buffered saline were added. 

Ninety-one in-patients were included; all were confirmed to have COVID-19 with an NP, mid-turbinate, or nasal swab tested in a clinical laboratory in Toronto. The median age was 66 years (range 23-106), 39 (43%) were female, 70 (77%) had at least one comorbidity, and 12 (13%) were immunocompromised. Eighteen (20%) had a household contact as the suspected source of exposure. On admission, 66 (73%) had fever and 68 (75%) had cough.

The median time from illness onset to hospital admission was 6 days (IQR 2-9) and 27 (30%) required intensive care. The median time from illness onset to collection of the tested specimens was 12 days (IQR 9-15). As of June 5 th , 3 (3%) remained hospitalized, 82 (90%) were discharged, and 6 (7%) had died. (Table) . Using saliva only would have detected 15/17 (88%), 25/38 (66%), and 12/17 (71%) patients in their first, second, and third/fourth week of illness, respectively (Table) . 

In this sample of 91 in-patients, NP swabs were 17% more sensitive than saliva overall. Sensitivity of both types of specimens was highest in the first week of illness, when viral concentrations have been reported to be highest [4, 9] . The difference in sensitivity between NP swabs and saliva was 6% if collected in the first week of illness and 20% if collected in the second week of illness or later. Our data suggest that NP swabs are more sensitive than saliva for SARS-CoV-2 detection, especially if the patient is later in illness.

A c c e p t e d M a n u s c r i p t 7 Our data also suggest that neither a single NP swab nor a single saliva specimen is 100% sensitive for the detection of COVID-19. This is consistent with prior literature [10], emphasizing that a single negative test does not rule out disease in patients with a high pretest probability of COVID-19. Repeated samples may improve yield. For example, among patients with a high pre-test probability for COVID-19 and a negative NP swab, repeating the NP swab and also collecting a saliva sample may be considered, as saliva sampling is noninvasive and 11% of patients in this study with at least one positive specimen were only positive in their saliva.

There are several limitations to this analysis. As these patients were originally diagnosed using NP, mid-turbinate, or nasal swabs, it is possible that there is a bias towards subsequent NP swabs versus other specimens being positive. We used a single detection system (Seegene), and other platforms may have yielded different results. We simply asked patients to spit a teaspoon of saliva into a specimen container; it is possible that some patients did not provide a full teaspoon of saliva, and this may in part explain the gap in sensitivity between NP swabs and saliva. It is also possible that other methods, such as throat washing with normal saline, would have improved yield. One small study found throat washing to be significantly more sensitive than NP swabs for SARS-CoV-2 detection, possibly enabling the acquisition of more epithelial cells [11] . Throat washing is easy to self-collect and should be further investigated as a non-invasive alternative to NP swabs and other invasive swabs such as oropharyngeal swabs.

A c c e p t e d M a n u s c r i p t 8 In conclusion, NP swabs were more sensitive than saliva for SARS-CoV-2 detection, particularly among patients beyond the first week of illness. Notably, however, NP swabs were only 6% more sensitive than saliva among the 18 sample pairs collected in the first week of illness in this study. This raises the possibility that NP swabs and saliva are equivalent early in illness, but this requires study in a larger sample. More data are also needed to assess testing on different platforms and to assess the sensitivity of different specimen types in asymptomatic patients or those whose illness does not require hospitalization. 

Michael's Hospital

Agron Plevneshi

David Richardson (William Osler Health System

BC Centre for Disease Control. COVID-19 Care -Lab Testing

Evaluating the accuracy of different respiratory specimens in the laboratory diagnosis and monitoring the viral shedding of 2019-nCoV infections

Virological assessment of hospitalized patients with COVID-2019

Consistent Detection of 2019 Novel Coronavirus in Saliva

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study

Saliva is more sensitive for SARS-CoV-2 detection in COVID-19 patients than nasopharyngeal swabs. medRxiv

How to Obtain a Nasopharyngeal Swab Specimen

We are grateful to the patients with COVID-19 who have agreed in difficult circumstances to help with research, and to the many laboratory, infection prevention and control, public